TRANSPLANT Act of 2021 became law 107 days after introduction, with cosponsors from both parties
Written by the Congressional Research Service [2]. 95 words.
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
- Committees
- House Energy and Commerce Committee
Senate Health, Education, Labor, and Pensions Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 6 of 154 bills enacted since 2013
- Text versions
- 5, from enrolled bill to public law · 684 words
- Subjects
- Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversightGovernment studies and investigationsHealth programs administration and funding +3 more
- Latest action
- May 26, 2021: Became Public Law No: 117-15.
- Records
- Congress.gov · Bill text
Each bill appears once, under its strongest link. 1 in all.
Related, per CRS or House · 1
- 117th S. 288 TRANSPLANT Act of 2021 D · Introduced